03:44 AM EST, 02/12/2026 (MT Newswires) -- Sanofi ( SNY ) said Thursday it has named Belen Garijo as its next chief executive officer, effective April 29.

Garijo will succeed Paul Hudson, after the board decided not to renew his director mandate, making Feb. 17 as his last day as CEO.

The drugmaker said it has appointed Olivier Charmeil, executive vice president of General Medicines and a member of the executive committee, as interim CEO during the transition.

Garijo previously spent 15 years at Sanofi ( SNY ), also served as a board member at L'Oreal and as CEO of Germany's Merck ( MRK ) , the company added.